Back

The oral administration of colchicine prevents the progression of aortic aneurysm

2 September 2019 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Vascular remodelling from capillaries to aorta Drugs, Drug Targets ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Hideyuki Okawa

Nagoya University, Nagoya (Japan)

6 More presentations in this session

Presentation thumbnail
Microcirculation injury is involved in anthracycline-induced cardiac toxicity
Mr C. Galan (Madrid, ES)
Abstract Slides
Presentation thumbnail
Coronary vulnerable plaque development is promoted by multidirectional wall shear stress
Mrs A. Hoogendoorn (Adelaide, AU)
Abstract
Presentation thumbnail
Tyrosine kinase inhibitor nilotinib increases atherosclerosis burden in ApoE knock-out mice
Doctor G. Detriche (Paris, FR)
Abstract Slides
Presentation thumbnail
Empagliflozin, a SGLT2 inhibitor, attenuates endothelial dysfunction and atherogenesis by inhibiting inflammatory responses in the vasculature and adipose tissue in diabetic apolipoprotein E-deficient
Doctor B. Ganbaatar (Tokushima, JP)
Abstract Slides
Presentation thumbnail
Functional deficiency in activating fcgamma receptor protects against aortic abdominal aneurysm in mice
Ms L. Lopez Sanz (Madrid, ES)
Abstract

Access the full session

Session thumbnail
Vascular remodelling from capillaries to aorta

The Event

Event poster

ESC Congress 2019

2 September 2019 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources